Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07224152 NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell… |
NBTXR3 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · The University of Texas M. D. Anderso… | 2026-03-27 → 2030-08-30 | Ouvrir |
| NCT07827573 kalitERA — A Study to Learn How Well Participants With a Specific Type … |
Giredestrant | Cancer | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Hoffmann-La Roche | Non communiqué | 2026-10-30 → 2032-11-30 | Ouvrir |
| NCT07181109 ZENITH — Zilebesiran in Patients With Hypertension Not Adequately Contr… |
Zilebesiran | Hypertension | Phase 3 | RECRUITING | En attente / non publié | Alnylam Pharmaceuticals | United States, Argentina, Australia, Austria, Belgium… | 2025-09-22 → 2030-09-23 | Ouvrir |
| NCT06862674 Clinical Exploration of NEUROMARK System in Participants With Chronic M… |
NEUROMARK System | Migraine | Non applicable | COMPLETED | En attente / non publié | Neurent Medical | United States · Ascension St. Vincent, Anderson, Unit… | 2024-09-06 → 2026-01-21 | Ouvrir |
| NCT07826910 VOR-GRIP — Effect of Atogepant on the Vestibulo-Ocular Reflex in Health… |
Atogepant 60 mg | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Fundación de Investigación Bioméd… | Switzerland · University Hospital Zurich, Department … | 2027-01-01 → 2028-12 | Ouvrir |
| NCT06401642 Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatme… |
Zavegepant | Migraine | Phase 4 | RECRUITING | En attente / non publié | University of South Florida | United States · Mayo Clinic in Arizona, Phoenix, Unit… | 2024-03-22 → 2027-03 | Ouvrir |
| NCT07642414 A Comprehensive Digital Care Program for Migraine Management |
Neuromodulation Wearable Device | Migraine | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Hinge Health, Inc | United States · Hinge Health, Inc., San Francisco, Un… | 2026-07-09 → 2026-11 | Ouvrir |
| NCT06388707 A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focus… |
NaviFUS System | Épilepsie | Phase 1/2 | RECRUITING | En attente / non publié | NaviFUS Corporation | United States · Brigham and Women's Hospital, Boston,… | 2024-09-13 → 2027-10-31 | Ouvrir |
| NCT05339126 RNS System LGS Feasibility Study |
RNS System | Épilepsie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | NeuroPace | United States · Emory University, Atlanta, United Sta… | 2022-10-04 → 2026-12-31 | Ouvrir |
| NCT02539134 TAK-935 Multiple Rising Dose Study in Healthy Participants |
TAK-935 | Épilepsie | Phase 1 | COMPLETED | En attente / non publié | Takeda | United States · Austin — centre non communiqué, Austi… | 2015-09 → 2016-04 | Ouvrir |
| NCT02497235 A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S… |
TAK-935 | Épilepsie | Phase 1 | COMPLETED | En attente / non publié | Takeda | United States · New Haven — centre non communiqué, Ne… | 2015-07 → 2016-01 | Ouvrir |
| NCT07821697 TRCE — Translational Recording and Characterization of Epilepsy Signals… |
EEG Record only | Épilepsie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Adraxe Corp. | United States · University of Minnisota, Minneapolis,… | 2026-10-15 → 2027-12-31 | Ouvrir |
| NCT07823465 AURORA — RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A… |
NeuroPace RNS System | Épilepsie | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | NeuroPace | United States · OM1's Central Site (Virtual Site), Wa… | 2026-09-14 → 2027-05 | Ouvrir |
| NCT07110454 DETECT LTFU — Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up |
Previous receipt of the Minder Sy… | Épilepsie | À vérifier | RECRUITING | En attente / non publié | Epiminder America, Inc. | United States · Atrium Health Neurosciences Institute… | 2025-12-23 → 2029-01 | Ouvrir |
| NCT06118255 ORCHID — A Study to Evaluate Safety, Tolerability, and Pharmacokinetics… |
fenfluramine | Épilepsie | Phase 3 | COMPLETED | En attente / non publié | Hospital Ruber Internacional | United States, Belgium, Germany, Italy, United Kingdo… | 2024-05-21 → 2026-09-01 | Ouvrir |
| NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children an… |
LP352 | Épilepsie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Longboard Pharmaceuticals | United States, Australia, Belgium, Brazil, Canada, Ch… | 2024-09-25 → 2026-12-31 | Ouvrir |
| NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental … |
LP352 | Épilepsie | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Longboard Pharmaceuticals | United States, Australia, Belgium, Brazil, China, Fra… | 2025-02-12 → 2027-12-17 | Ouvrir |
| NCT06682767 A Nutritional and Pharmacological Intervention for Body, Brain, and Lon… |
Rapamycin | Alzheimer | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Azienda Ospedaliero-Universitaria… | United States · Cedars Sinai Medical Center, Los Ange… | 2026-11 → 2028-06 | Ouvrir |
| NCT06862557 Pulsed Electromagnetic Field Treatment With Dementia Patients |
ECHS AD Device | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Herrick Medical LLC | United States · University of Miami, Boca Raton, Unit… | 2025-04-01 → 2027-09-30 | Ouvrir |
| NCT06079190 PROGRESS-AD — Efficacy and Safety of GSK4527226 [AL101] in Participants… |
GSK4527226 | Alzheimer | Phase 2 | TERMINATED | En attente / non publié | GlaxoSmithKline | United States, Argentina, Australia, Canada, Finland,… | 2023-10-20 → 2026-08-18 | Ouvrir |
| NCT02720445 Memory Improvement Through Nicotine Dosing (MIND) Study |
Nicotine Transdermal Patch | Alzheimer | Phase 2 | COMPLETED | En attente / non publié | University of Southern California | United States · Augusta University Movement and Memor… | 2017-02-22 → 2025-09-16 | Ouvrir |
| NCT05295615 Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Dis… |
ECHS AD Device | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Herrick Medical LLC | United States · Hackensack Medical Center, Hackensack… | 2023-05-01 → 2027-09-30 | Ouvrir |
| NCT05469360 Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of… |
NIO752 | Alzheimer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Finland, France, Spain, Sweden · Novartis Investigati… | 2023-02-23 → 2027-09-24 | Ouvrir |
| NCT07827196 Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Dou… |
High frequency transcranial rando… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Anhui Medical University | China · Anhui Medical University, Hefei, Anhui 230032… | 2026-09-01 → 2027-09-01 | Ouvrir |
| NCT07221344 Study of ARO-MAPT-SC in Healthy Participants and Participants With Earl… |
ARO-MAPT-SC | Alzheimer | Phase 1/2 | RECRUITING | En attente / non publié | Arrowhead Pharmaceuticals | Canada, New Zealand · Research Site 1, Grafton, New Z… | 2025-11-18 → 2027-06 | Ouvrir |